Chai Nelson's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Feb 21, 2025
- Accession no.
- 0001127602-25-006235
- Filed
- Feb 21, 2025
- Trade date
- Nov 7, 2024-Feb 19, 2025
- Filing delay
- 106 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $11.0K. Open-market sales total $8.45K. It was filed 106 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chai NelsonCIK 0001299914 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | Common Stock | PPurchaseAcquired | +16 | $555.89 | +$8,894.24 | 14,264 | Direct | |
| Dec 9, 2024 | Common Stock | PPurchaseAcquired | +4 | $535.93 | +$2,143.72 | 14,268 | Direct | |
| Feb 19, 2025 | Common Stock | SSaleDisposed | −16 | $528.09 | −$8,449.44 | 14,252 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.